Novartis’ Sandoz, following Pfizer’s lead, launches 2nd carcinogen-related drug recall this week

Novartis’ Sandoz, following Pfizer’s lead, launches 2nd carcinogen-related drug recall this week
fkansteiner
Wed, 03/23/2022 – 14:55